KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.95

Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial.

Java Walladbegi, Roger Henriksson, Björn Tavelin, Anncarin Svanberg, Gunnar Larfors, Martin Jädersten, Fredrik Schjesvold, Aram Mahdi, Karin Garming Legert, Douglas E Peterson, Mats Jontell

Bone Marrow Transplant 57(2) 191-197

PMID34728786
PMCIDPMC8821013
DOI10.1038/s41409-021-01512-6
发表日期2021-11-03
入排依据:The trial is a randomized, blinded, Phase III oncology trial in humans with original results, but it evaluates a cooling device (device vs. ice) and does not include a drug-containing intervention. The primary endpoint is a patient-reported symptom score (Oral Mucositis Assessment Scale), not a time-to-event efficacy endpoint like OS, PFS, or similar.
摘要

摘要

Cryoprevention (CP) using ice (IC) is an effective strategy to prevent chemotherapy-induced oral mucositis (OM). However, the use of IC may cause adverse reactions and requires water of safe quality to minimize risk of serious infections. This randomized, blinded, parallel group, phase 3 trial was conducted in five Scandinavian centers. Eligible patients were diagnosed with multiple myeloma or lymphoma, scheduled to receive conditioning with high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation (ASCT). Patients were assigned to cooling with IC or a novel intraoral cooling device (ICD). The primary outcome was the highest OM score during the study period, expressed as peak value on the Oral Mucositis Assessment Scale (OMAS-total). When the entire study population (n = 172) was analyzed for peak OMAS-total, the two cooling methods were equally effective. However, when the lymphoma group was analyzed separately, the ICD significantly reduced the peak OMAS-total score to a greater extent compared to IC (x̄ ± SD; 1.77 ± 1.59 vs. 3.08 ± 1.50; p = 0.047). Combined with existing evidence, the results of the present trial confirm that CP is an effective method to prevent OM. ClinicalTrials.gov. NCT03203733.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。